TAP News 76.79 09/15/2014 10:08:35 Molson Coors Brewing Company

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Molson Coors Brewing Company (TAP) 76.79 $TAP

Early Glance: Beverages companies
AP - 31 mins ago
NEW YORK (AP) — Shares of some top beverages companies are mixed at 10 a.m.:


Stocks open lower ahead of Fed meeting
By STEVE ROTHWELL - AP - 58 mins ago
NEW YORK (AP) — U.S. stocks dropped in early trading Monday ahead of this week's potential pivotal Federal Reserve meeting. The Fed is nearing the end of its bond-buying stimulus program, and investors will be looking for indications of when policy makers will start raising interest rates.

Final Glance: Beverages companies
AP - Fri Sep 12, 5:02PM CDT
NEW YORK (AP) — Shares of some top beverages companies were mixed at the close of trading:

Midday Glance: Beverages companies
AP - Fri Sep 12, 12:19PM CDT
NEW YORK (AP) — Shares of some top beverages companies are mixed at 1 p.m.:

Molson Coors Named to Dow Jones Sustainability Index for Third Consecutive Year
Business Wire - Thu Sep 11, 12:36PM CDT
Molson Coors Brewing Company (NYSE: TAP) has maintained its listing on the World Index for the third consecutive year and North America Index for the fourth consecutive year. The Dow Jones Sustainability World Index recognizes the top 10 percent of global companies, making Molson Coors one of just eight food and beverage companies listed.

SmarTrend Watching for Potential Rebound in Shares of Molson Coors Brewing After 2.27% Loss
Comtex SmarTrend(R) - Tue Sep 09, 4:42PM CDT
Molson Coors Brewing (NYSE:TAP) traded in a range yesterday that spanned from a low of $70.03 to a high of $71.13. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $71.18 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of Molson Coors Brewing to Potentially Rebound after Yesterday's 2.27% Sell Off
Comtex SmarTrend(R) - Tue Sep 09, 4:41PM CDT
Molson Coors Brewing (NYSE:TAP) traded in a range yesterday that spanned from a low of $70.03 to a high of $71.13. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $71.18 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

How Will Molson Coors Brewing (TAP) Stock Be Affected By This Analyst Action?
at The Street - Tue Sep 09, 8:20AM CDT
Molson Coors Brewing (TAP) shares were downgraded to 'neutral' by analysts at BTIG Research on Tuesday.

Downgrade Alert for Molson Coors Brewing (TAP)
Comtex SmarTrend(R) - Tue Sep 09, 8:04AM CDT
Molson Coors Brewing (NYSE:TAP) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $71.82 on volume of 1.2 million shares, above average daily volume of 1.2 million. There is potential upside of 10.9% for shares of Molson Coors Brewing based on a current price of $71.82 and an average consensus analyst price target of $79.62. Molson Coors Brewing shares should encounter resistance at the 50-day moving average (MA) of $72.50 and support at its 200-day MA of $62.31.

How 5 Summer Industries Stay Warm in Winter
at The Street - Mon Sep 08, 7:30AM CDT
Amusement parks and sunscreen manufacturers are among the warm-weather businesses that figured out how to thaw off-peak sales.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 129

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 21

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 344

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 259

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 378

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 305

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading

Top 5 Most Recently Viewed Articles

Dollar Tree's Earnings Drop and Future Outlook Challenges

Updated Category News Views 123

Highlights from Dollar Tree's Earnings Report Dollar Tree has encountered significant challenges in the market after revealing that its second-quarter earnings did not meet analysts' expectations. The discount retailer reported a year-over-year decline in net income, attributing this downturn to the considerable difficulties posed by the current economic conditions. This...

Continue Reading
The Risks of Banking Standards: A Deep Dive into Safety

Updated Category News Views 411

Understanding Current Banking Risks Banks are integral to the economy, ensuring that funds flow smoothly throughout various sectors. However, recent decisions to relax standards for banks have raised significant concerns about potential risks that may arise. Weiss Ratings, a prominent name in independent bank safety evaluations, has recently highlighted unsettling changes...

Continue Reading
Koch and OCP Forge Ahead with New Joint Venture

Updated Category News Views 46

Tying Two Giants Together When industrial titans like Koch Ag & Energy Solutions and Moroccan powerhouse OCP decide to double down on their existing partnership, anyone with a stake in iron and fertilizer industries ought to take note. It's not every day that two behemoth corporations decide to lace up together in a joint venture, signaling a potential shift in market...

Continue Reading
Youlife Group Inc. Moves to Expand with Strategic Acquisitions

Updated Category News Views 213

Youlife Group Inc. Expands Market Reach with Key Acquisitions Youlife Group Inc. (NASDAQ: YOU), recognized as a leading provider of blue-collar lifetime services, has exciting plans to make strategic acquisitions aimed at bolstering its market position. This initiative comes as Youlife enters into non-binding term sheets with the controlling shareholders of four notable...

Continue Reading
Advancements in Wet AMD Treatment: Outlook Therapeutics Updates

Updated Category News Views 326

Significant Milestones for Outlook Therapeutics ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pioneering biopharmaceutical company, has made notable strides towards securing regulatory approval for its innovative treatment for wet age-related macular degeneration (wet AMD). Their investigational product, ONS-5010 (bevacizumab-vikg), is an ophthalmic...

Continue Reading